Newsroom

LONDON--(BUSINESS WIRE)--  DMO-TAS041/3677/002         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A071\26 2 June 2026   PRESS NOTICE   RESULT OF THE SALE BY AUCTION OF £3250 MILLION OF 4⅝% GREEN GILT 2037The United Kingdom Debt Management Office ("DMO") announces that the auction of £3,250 million of 4⅝% Green Gilt 2037 (ISIN Code: GB00BVP99905) has been allocated as follows:(Note: all prices in this notice are quoted in pounds and p...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 01.06.2026 FTAI IE000YIQZ0H6 200,002.00 USD 6,536,424.20 32.682  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 01.06.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,795,720.71 25.305  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 01.06.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,967,335.03 24.372  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 01.06.2026 FTEI.LN IE000TIZ5AP4 200,002.00 EUR 4,147,136.29 20.735  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Computershare Trustees (Jersey) Limited as trustee of the Schroders Employee Benefit Trust (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. Fo...

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. annonce aujourd'hui la finalisation de son acquisition d'Eucalyptus, la société mère de Juniper, marquant la plus récente d'une série d'importantes initiatives et d'investissements de l'entreprise au Canada. Depuis son lancement en 2025, Hims & Hers a déjà changé la donne au Canada, devenant ainsi la première plateforme à proposer le sémaglutide générique aux Canadiens admissibles. En combinant la plateforme éprouvée de Juniper avec la...

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advance...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on the earlier acquisitions of ZAVA and Livewell, Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France, Germany, Ireland, Spain, and Japan. Continuing to expand internationally will enable Hims & Hers to lead the next...

TOKYO--(BUSINESS WIRE)--Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure behind a platform that supports weight management care for people in Japan, a market the company approaches with deep respect for its distinct healthcare values and the tru...